Cancer Therapy News and Research

RSS

Access Pharmaceuticals issued U.S. patent

This patent, entitled "O,O'-Amidomalonato and N,O-Amidomalonato Platinum Complexes" is one of a series of patents and patent applications owned by Access which provides intellectual property protection to ProLindac and related tumor-targeted platinum compounds.

30 Jan 2007

Small molecule targets weak mRNA

A new strategy for fighting cancer aims to make its genes get lost in translation, according to a report in the January 26, 2007, issue of the journal Cell.

28 Jan 2007

Nanoparticles yield delivery tools for therapeutic nucleic acids

Cancer researchers hold great hope that nucleic acid-based therapeutics, such as anticancer genes, antisense oligonucleotides, and small interfering RNA (siRNA) molecules, will prove to be powerful antitumor agents.

16 Jan 2007

Young single men are more likely to bank sperm before testicular cancer treatment

A quarter of men with testicular cancer banked their sperm before treatment, but only six per cent of those actually used the sperm to father a child, according to a study published in the January issue of the UK-based urology journal BJU International.

8 Jan 2007

First year of cancer treatment costs patients $2.3 billion in lost time

The time that cancer patients nationwide spend when they travel to, wait for and receive inpatient and outpatient treatment costs an estimated $2.3 billion in the first year after diagnosis, according to a study published on Wednesday in the Journal of the National Cancer Institute, the AP/South Florida Sun-Sentinel reports.

7 Jan 2007

Computational model for cancer invasion

Vito Quaranta clicks on a small black dot on his computer screen. The dot - which represents about a thousand cancer cells - begins to "grow," morphing into a mass with finger-like projections that looks like an invasive tumor.

2 Dec 2006

Cancer Research Technology and University of Manchester announce collaboration in oncology with AstraZeneca

Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, and The University of Manchester have entered into an agreement with AstraZeneca to establish a clinical pharmacology biomarker research and discovery collaboration.

20 Nov 2006

External-beam radiation therapy safe for breast cancer

External-beam radiation therapy for early-stage breast cancer can be delivered safely and in a shorter course that eliminates as much as two weeks from conventional treatment.

8 Nov 2006

Nanoparticles for two-photon photodynamic therapy in living cells

Photodynamic therapy (PDT) uses a combination of ultraviolet or visible light and a light-sensitive chemical, or photosensitizer, to kill cancer cells using reactive oxygen.

6 Nov 2006

Breast cancer patients may benefit from new accelerated treatment

Women with early-stage breast cancer may benefit from a new, accelerated approach to radiation therapy making their course of treatment shorter, according to a new study released today in the International Journal for Radiation Oncology-Biology-Physics, the official journal of ASTRO.

31 Oct 2006

Bright light band aid - high tech way to treat skin cancer

Scientists in Scotland have come up with a revolutionary way of treating common skin cancers.

31 Oct 2006

Sequencing of chemotherapy and radiation therapy for early breast cancer

For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.

30 Oct 2006

Scientists step toward next generation of cancer-beating drugs

Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.

From The University of Manchester 26 Oct 2006

16 year old cancer victim dies after overdoses of radiation

A 16 year old cancer victim who was inadvertently given more than 17 overdoses of radiation during treatment for a brain tumour, has died at home nine months later.

23 Oct 2006

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

Targeted tumor therapy lobs toxic payloads directly into tumors to destroy cancer cells while leaving normal cells unharmed.

20 Oct 2006

Nanoparticle encapsulation improves bioavailability of leukemia drug

Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.

9 Oct 2006

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.

5 Oct 2006

Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice

A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.

2 Oct 2006

New target for cancer therapy identified by Australian researchers

A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development.

21 Sep 2006

Curcumin useful in the fight against colorectal cancer

Looking for a cancer cure? Try the spice rack. In the last few years, that tactic has proved productive for researchers investigating turmeric, a curry spice used for centuries in Indian traditional medicine.

19 Sep 2006